Study challenges migraine-Parkinson’s connection

Contrary to previous research, a new study of female participants finds no link between migraine and the risk of developing Parkinson’s disease. The study was published on August 21st, 2024, in the online issue of Neurology®, the medical journal of the American Academy of Neurology.

Duchenne Muscular Dystrophy Gene Therapy

The FDA’s recent expanded approval of delandistrogene moxeparvovec (Elevidys) widened access to the gene therapy to include ambulatory and non-ambulatory Duchenne muscular dystrophy patients ages

July 2, 2024

Evaxion partners with Afrigen Biologics to develop mRNA gonorrhea vaccine

A 3D illustration of Neisseria gonorrhoeae, the bacterium responsible for the sexually transmitted infection gonorrhea. mRNA vaccine trials are leading the way in the field

September 21, 2023

Trodelvy fails PhIII lung cancer study in blow to Gilead’s ADC expansion plans

Gilead’s antibody-drug conjugate Trodelvy failed to significantly extend survival in a late-stage lung cancer study, the pharma company said Monday morning. The Phase III EVOKE-01

January 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.